The Oncology Institute, Inc. TOI Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from The Oncology Institute, Inc.’s reported figures.
Based on the most recent quarter.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s debt-to-equity?
- The Oncology Institute, Inc. (TOI) reported debt-to-equity of 20.2× in Q1 2025.
- How has The Oncology Institute, Inc.'s debt-to-equity changed year-over-year?
- The Oncology Institute, Inc.'s debt-to-equity increased by 595.4% year-over-year, from 2.9× to 20.2×.
- What is the long-term trend for The Oncology Institute, Inc.'s debt-to-equity?
- Over 4 years (2020 to 2024), The Oncology Institute, Inc.'s debt-to-equity has grown at a 199.9% compound annual growth rate (CAGR), from 0.4× to 34.3×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.